Pancreatic Cancer Research

ResearcherUniversity of Nebraska–LincolnActive in the last 2 years

Scott E. Mulder

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7411-9165; OpenAlex author ID A5046060328. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers

Papers 8

  1. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Co-author DOI 10.1038/s41556-024-01372-4↗
  2. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 … Co-author DOI 10.1038/s41556-024-01417-8↗
  3. ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215981↗
  4. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41388-021-02132-6↗
  5. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Co-author DOI 10.1053/j.gastro.2021.06.045↗
  6. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia. Co-author DOI 10.1016/j.canlet.2020.07.025↗
  7. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia. Co-author DOI 10.1007/978-1-4939-8879-2_28↗
  8. Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.jproteome.7b00246↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pankaj Kumar Singh · 8 shared papers, 2017–2024 · strength 0.97
  2. Surendra Kumar Shukla · 8 shared papers, 2017–2024 · strength 0.97
  3. Nina V. Chaika · 6 shared papers, 2017–2024 · strength 0.72
  4. Aneesha Dasgupta · 5 shared papers, 2019–2024 · strength 0.65
  5. Chunbo He · 5 shared papers, 2021–2024 · strength 0.65
  6. Ravi Kumar Thakur · 5 shared papers, 2021–2024 · strength 0.65
  7. Divya Murthy · 5 shared papers, 2020–2024 · strength 0.60
  8. Ryan J. King · 5 shared papers, 2020–2024 · strength 0.60
  9. Kuldeep Singh Attri · 5 shared papers, 2020–2024 · strength 0.60
  10. Sai Sundeep Kollala · 3 shared papers, 2023–2024 · strength 0.44
  11. Michael Anthony Hollingsworth · 3 shared papers, 2022–2024 · strength 0.40
  12. Paul M. Grandgenett · 3 shared papers, 2022–2024 · strength 0.40
  13. Kamiya Mehla · 3 shared papers, 2021–2024 · strength 0.36
  14. Tuo Hu · 3 shared papers, 2021–2024 · strength 0.36
  15. Robert Powers · 3 shared papers, 2017–2024 · strength 0.34
  16. Teklab Gebregiworgis · 3 shared papers, 2017–2024 · strength 0.34
  17. Jaime Abrego · 3 shared papers, 2017–2022 · strength 0.31
  18. Rosa F. Hwang · 2 shared papers, 2024 · strength 0.28
  19. Ajay Jain · 2 shared papers, 2024 · strength 0.28
  20. Vikrant Rai · 2 shared papers, 2024 · strength 0.28
  21. Joshua J. Souchek · 2 shared papers, 2024 · strength 0.28
  22. Barish H. Edil · 2 shared papers, 2024 · strength 0.28
  23. Kathryn Elaine Wellen · 2 shared papers, 2024 · strength 0.28
  24. Amarnath (Amar) Natarajan · 2 shared papers, 2024 · strength 0.28
  25. Susanna Varkey Ulahannan · 2 shared papers, 2024 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.